These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15734201)

  • 21. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA
    Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
    Strnad V; Major T; Polgar C; Lotter M; Guinot JL; Gutierrez-Miguelez C; Galalae R; Van Limbergen E; Guix B; Niehoff P; Lössl K; Hannoun-Levi JM
    Radiother Oncol; 2018 Sep; 128(3):411-420. PubMed ID: 29691075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations.
    Lang S; Nulens A; Briot E; Kirisits C; De Brabandere M; Dumas I; Dimopoulos J; Petrow P; Georg D; Van Limbergen E; Haie-Meder C; Pötter R
    Radiother Oncol; 2006 Feb; 78(2):185-93. PubMed ID: 16466820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results.
    Mahal BA; Ziehr DR; Hyatt AS; Neubauer-Sugar EH; O'Farrell DA; O'Leary MP; Steele GS; Niedermayr TR; Beard CJ; Martin NE; Orio PF; D'Amico AV; Devlin PM; Nguyen PL
    Brachytherapy; 2014; 13(5):442-9. PubMed ID: 24880584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy.
    Sasaki H; Kido M; Miki K; Kuruma H; Takahashi H; Aoki M; Egawa S
    Int J Urol; 2014 Jun; 21(6):572-7. PubMed ID: 24372730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study.
    Kaljouw E; Pieters BR; Kovács G; Hoskin PJ
    Radiother Oncol; 2016 Jan; 118(1):122-30. PubMed ID: 26549865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK; Adams MT; Motta J
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial high-dose-rate brachytherapy in eyelid cancer.
    Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
    Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brachytherapy for clinically localized prostate cancer: optimal patient selection.
    Kollmeier MA; Zelefsky MJ
    Arch Esp Urol; 2011 Oct; 64(8):847-57. PubMed ID: 22052766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy.
    Siebert FA; Kirisits C; Hellebust TP; Baltas D; Verhaegen F; Camps S; Pieters B; Kovács G; Thomadsen B
    Radiother Oncol; 2020 Jul; 148():51-56. PubMed ID: 32335363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostatourethral-rectal fistula after prostate brachytherapy.
    Theodorescu D; Gillenwater JY; Koutrouvelis PG
    Cancer; 2000 Nov; 89(10):2085-91. PubMed ID: 11066049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectum dose reduction and individual treatment plan optimization for high-dose-rate prostate brachytherapy.
    Bölling T; Moustakis C; Elsayed H; Müller SB; Weining C; Reinartz G; Ernst I; Willich N; Könemann S
    Brachytherapy; 2007; 6(4):280-5. PubMed ID: 17991624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High dose-rate brachytherapy of prostate cancer utilising Iridium-192 after-loading technique: technical and methodological aspects.
    Edgren M; Ekelund AM; Albertsson P; Lundberg LM; Ullen A; Levitt S; Nilsson S; Lennernäs B
    Int J Oncol; 2006 Dec; 29(6):1517-24. PubMed ID: 17088991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience.
    Aluwini S; van Rooij PH; Kirkels WJ; Jansen PP; Praag JO; Bangma CH; Kolkman-Deurloo IK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1480-5. PubMed ID: 22285661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
    Martinez A; Gonzalez J; Stromberg J; Edmundson G; Plunkett M; Gustafson G; Brown D; Yan D; Vicini F; Brabbins D
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1019-27. PubMed ID: 7493828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.